Previous Advocacy Updates

CMS extends deadline for 2017 MIPS targeted review and House committee reviews barriers to value-based care.

The House passed the Local Coverage Determination Clarification Act, which aims to improve accountability and transparency in the process Medicare contractors use to make local coverage decisions.

LCD bill moves from Committee to House Vote lacking key provision and CAP comments on proposed 2019 Medicare regulation on payments for pathologists.

In response to CAP’s opposition, the USPSTF reconsiders change to cervical cancer screening recommendations.

The CMS proposes two tracks, updates EMR requirements in ACO rule and CAP encourages national research program to have specimen collection guidelines.

CAP, ACLA and others urge Congress to reform PAMA and a chance to win an Apple Watch just for telling us about your STATLINE readership experience.

More senators and representatives signed on as co-sponsors to the Local Coverage Determination (LCD) Clarification Act after CAP members lobbied their elected officials to support the legislation that increases transparency and accountability in the LCD process.

Pathologists continue gain congressional support for Medicare LCD reform and HHS reports difficulty with PAMA implementation.

The CMS proposes regulations that will impact pathology payment in 2019 and the NH Network Adequacy law takes effect.

The CMS proposed its 2019 Medicare Physician Fee Schedule and new rules for next year’s Merit-based Incentive Payment System (MIPS).

The CMS sets enforcement discretion period for Laboratory Date of Service Policy and eligible pathologists can request targeted review of their 2019 MIPS Payment Adjustments.

The CAP advocated for fair clinical laboratory payments for new CPT codes for the CMS to consider including in the 2019 Medicare clinical laboratory fee schedule (CLFS).

The CAP advocated for the CMS to revise its proposed inpatient payment system regulation that would make hospital standard charges public, increase emphasis on interoperability of HIT, ensure consistent payment rates for CAR-T cell therapy settings, and further extend its “14-day rule” policy to allow laboratories to bill directly for molecular pathology tests. Moreover, CAP members and leaders continue to urge their elected officials to support legislation to increase transparency and accountability in the Medicare Local Coverage Determination (LCD) process.

AMA Special Report: CAP Protects Accurate Diagnoses for Patients at 2018 AMA Meeting.

CAP leads support of Health Plan Network Adequacy with multiple patient advocacy groups and NJ governor signs balance billing measure into law.

2018 MIPS reporting resources now available for Pathologists.

Pathologists’ action leads to more LCD reform support and CMS to release 2017 MIPS scores on July 1.

MIPS clinician eligibility tool available for Individuals and Group Practices

Pathologists lobby for Medicare LCD, PAMA reform at 2018 Hill Day

Pathologists to advocate for LCD, PAMA Reform at the 2018 Policy Meeting